title: Anejaculation as the presenting feature of pituitary microadenoma.
abstract: OBJECTIVE
  To describe the resolution of anejaculation associated with PRL excess by dopamine agonist treatment.
  
  
  METHODS
  Case report.
  
  
  METHODS
  Fertility clinic.
  
  
  METHODS
  Two men with anejaculation, in one case with associated infertility.
  
  
  METHODS
  Dopamine agonist treatment.
  
  
  METHODS
  Resolution of anejaculation and infertility.
  
  
  RESULTS
  Endocrine investigations in both men revealed low serum T, elevated PRL, and a pituitary microadenoma. Treatment with a dopamine agonist normalized serum hormone profiles and restored sexual function, with subsequent involution of the adenoma.
  
  
  CONCLUSIONS
  Prolactinoma manifesting as anejaculation is rare but responds readily to treatment with a dopamine agonist. Serum PRL should be measured in any man presenting with anejaculation.
authors.affiliation: Fertility Associates, Ascot Hospital, Remuera, Auckland, New Zealand.
authors.forename: Sasha
authors.initials: S
authors.lastname: Nair
authors.forename: Stella
authors.initials: S
authors.lastname: Milsom
mesh_terms: D000328:Adult; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004542:Ejaculation / Q000187:drug effects*; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D008297:Male; D010911:Pituitary Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D011388:Prolactin / Q000097:blood*; D015175:Prolactinoma / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D015854:Up-Regulation
chemical_list: D018491:Dopamine Agonists; D011388:Prolactin